| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.4 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |